Since there are no targeted therapies for SLC25A42 deficiency, we decided to supply pantothenic acid, the water‐soluble vitamin converted to CoA through a conserved biosynthetic process, to the patients in the attempt to rescue CoA levels. Here, SLC25A42 is linked to hyperinsulinemic hypoglycemia, familial, 4.